Drug Utilization Evaluation (DUE) of vancomycin: A cross-sectional study

Rezvani, Mina and Kharazmkia, Ali and Amiri, Ali and Esfahani, Monsef and Sherkatolabbasieh, Hamid Reza and Birjandi, Mehdi (2022) Drug Utilization Evaluation (DUE) of vancomycin: A cross-sectional study. Annals of Medicine and Surgery.

[img]
Preview
Text
113f.pdf

Download (1MB) | Preview

Abstract

Evaluating the use of antibiotics leads to identifying drug problems, preventing antibiotic resistance, and controlling the cost of medication. The aim of this study was to Drug Utilization Evaluation (DUE) of vancomycin. Methods This study was a descriptive retrospective cross-sectional study. Sampling method was the census. The information was collected through a checklist and referring to patients' files. Results 170 children and 120 adults who received vancomycin were studied. The dose of vancomycin in the studied adults was 40.6% and 61% was in accordance with the Uptodate guideline. Also, the duration of treatment in the studied children was 10.6% and 15.3% according to the Uptodate guideline and in adults 30%, 39.2% was in accordance with the Uptodate guideline. Also, the indication for vancomycin in children was 14.1% and 18.8% in accordance with the Uptodate guideline, and in adults 40% and 52.5% was in accordance with the Uptodate guideline. The highest initial diagnosis in children was RDS 54.1%, seizure 9.4%, jaundice 9.4% and pneumonia 8.2%, and in adults 30% CRF and 11.7% catheter. In children, the most common complications were related to shortness of breath 41.2%, fever 18.8% and jaundice 11.8%, and in adults were related to fever 32.5%, lethargy 26.7% and shortness of breath 20%, respectively.

Item Type: Article
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine, Health and Life Sciences > School of Medicine
Depositing User: samira sepahvandy
Date Deposited: 23 Aug 2022 04:24
Last Modified: 23 Aug 2022 04:24
URI: http://eprints.lums.ac.ir/id/eprint/3876

Actions (login required)

View Item View Item